MoneyWorks4Me

Cipla - Quaterly Results

13 May 2025 Evaluate
The revenue zoomed 18.86% to Rs. 47978.90 millions for the quarter ended March 2025 as compared to Rs. 40366.60 millions during the corresponding quarter last year.Net profit surges 51.26% to Rs. 14854.00  millions  from Rs. 9820.30 millions in the quarter ended March 2025.Operating profit for the quarter ended March 2025 rose to 16120.80 millions as compared to 13665.00 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 47978.90 40366.60 18.86 190448.50 165743.40 14.91 190448.50 165743.40 14.91
Other Income 2933.70 5386.10 -45.53 9847.20 10706.60 -8.03 9847.20 10706.60 -8.03
PBIDT 16120.80 13665.00 17.97 67631.60 55548.10 21.75 67631.60 55548.10 21.75
Interest 34.90 54.50 -35.96 151.10 202.50 -25.38 151.10 202.50 -25.38
PBDT 19032.50 13610.50 39.84 70427.10 55345.60 27.25 70427.10 55345.60 27.25
Depreciation 1477.00 1368.10 7.96 5738.90 5875.90 -2.33 5738.90 5875.90 -2.33
PBT 17555.50 12242.40 43.40 64688.20 49469.70 30.76 64688.20 49469.70 30.76
TAX 2701.50 2422.10 11.54 13111.70 12327.80 6.36 13111.70 12327.80 6.36
Deferred Tax -625.60 20.30 -3181.77 -491.50 60.90 -907.06 -491.50 60.90 -907.06
PAT 14854.00 9820.30 51.26 51576.50 37141.90 38.86 51576.50 37141.90 38.86
Equity 1615.20 1614.70 0.03 1615.20 1614.70 0.03 1615.20 1614.70 0.03
PBIDTM(%) 33.60 33.85 -0.75 35.51 33.51 5.96 35.51 33.51 5.96
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..